Sign Up And Receive Our Latest Promotions!
.svg){kind=small}
May 4 - 9
Seattle, WA
Visit our booth #4403
Accelerate your clinical research with Discovery, our AI-Driven data management & analysis platform
Meet our researchers on-site and get to know Discovery, our AI-driven analytics platform, enabling the early detection, accurate diagnosis, and effective monitoring of conditions like AMD, GA, DR, DME, and more.
We are glad to participate in both ARVO’s Imaging in the Eye Conference and ARVO's Annual Conference.
Stop by our booth to experience Discovery's capabilities and advantages! Feel free to bring your de-identified data on a USB stick, and witness our platform in action, processing your data in real-time!
Posters co-authored by RetinAI
See Discovery platform and AI models featured in the following poster presentations from RetinAI's Team and Collaborators
May 6
Correlations between GA lesions in FAF and Morphological outer retinal changes in OCT
🕐 3:00 - 4:45PM PT 👉 Add a bookmark in your calendar
📍Session AMD-2 Imaging I Poster board A0131
📖 Read the abstract
May 6
Natural History of Retinal Morphology in a Real-World GA Patient cohort: Insights from Automatic OCT Segmentation
🕐 3:00 - 4:45PM PT 👉 Add a bookmark in your calendar
📍Session AMD-2 Imaging I Poster board A0134
📖 Read the abstract
May 8
Impact of Fluid Volume Fluctuations assessed by AI on Visual Outcomes during Anti-VEGF Therapy in nAMD Eyes in the real world: FRB SPAIN-IMAGE project
🕐 10:30 - 12:15PM PT 👉 Add a bookmark in your calendar
📍Session AMD-3 Clinical Research I Poster board A0080
📖 Read the abstract
May 8
Geographic Atrophy Progression in Routine Clinical Practice: before and after Pegcetacoplan treatment
🕐 10:30 - 12:15PM PT 👉 Add a bookmark in your calendar
📍Session AMD-3 Clinical Research I Poster board A0115
📖 Read the abstract
May 8
On the Edge: Quantitative Analysis of Retinal Layer Thickness Surrounding Geographic Atrophy Lesions using OCT
🕐 2:15 - 4:00PM PT 👉 Add a bookmark in your calendar
📍Session Extended reality & machine learning in vision science I Poster board B0527
📖 Read the abstract
Presentations using our Discovery Platform
See Discovery platform and AI models featured in the following poster presentations from the industry
May 5
Faricimab for highly resistant CNV in wet age-related macular degeneration- 7 months observations using artificial intelligence
🕐 8:00 - 9:45AM PT
📍Session AMD-1 Anti-VEGF I Poster board B0293
📖 Read the abstract
May 6
Artificial intelligence in identifying key biomarkers in patients with neovascular age-related macular degeneration using optical coherence tomography
🕐 3:00 - 4:45PM PT
📍Session AI in the Retina I Poster board A0179
📖 Read the abstract
May 6
Artificial Intelligence- Enhanced OCT Biomarkers Analysis in Macula-Off Retinal Detachment Patients
🕐 3:00 - 4:45PM PT
📍Session AI in the Retina 1 I Poster board A0189
📖 Read the abstract
May 7
First results of the phase 2 BETTER trial using intravitreal ISTH0036, a selective TGF-β2 blocking antisense in AMD and DME
🕐 1:15 - 3:00PM PT
📍Session Retina/RPE treatment: New drugs, delivery methods, and mechanisms of action I Conference room: Yakima 1
📖 Read the abstract
Exploring the Factors Influencing Recurrence of Central Serous Chorioretinopathy using Machine Learning
🕐 1:15 - 3:00PM PT
📍Session AI in the Retina 2 I Poster board B0439
📖 Read the abstract
AI-Enhanced OCT Image Analysis for Inherited Retinal Diseases
🕐 1:15 - 3:00PM PT
📍Session AI in the Retina 2 I Poster board B0424
📖 Read the abstract
Ikerian AG (HQ)
Freiburgstrasse 3
3010 Bern
Switzerland
RetinAI US Inc. (US)
6 Liberty Square
#2498 Boston, MA 02109
United States
Imprint/Legal Notice | Data Processing Agreement | Privacy Notice | Created by Ikerian AG. All rights reserved 2016-2023 ©